8-[4-(2,2-Dimethylpropyl)-2-pyridinyl]-2-methylbenzofuro[2,3-b]pyridine
CAS: 1883377-30-7
Category: Organic Pharmaceutical Intermediates
| Purity | ≥97.0% (HPLC); ≥98.0% (HPLC); ≥99.0% (HPLC) |
| Molecular Formula | C23H24N2O |
| Molecular Weight | 344.45 |
| Appearance | Off-white to pale yellow crystalline powder |
| Packaging | 100 mg, 250 mg, 1 g, 5 g, 10 g, 25 g, 100 g, or 500 g amber glass bottle or aluminum foil bag with moisture-proof inner liner |
| Testing Indicators | Appearance — Visual inspection; Identification — LC-MS, HRMS, FTIR, 1H NMR and 13C NMR; Assay/Purity — HPLC (UV); Related substances — HPLC; Water content — Karl Fischer titration (USP <921>); Residual solvents — GC (USP <467>); Melting point — USP <741>; Elemental impurities — ICP-MS or ICP-OES; Structure confirmation — High-resolution mass spectrometry and multidimensional NMR spectroscopy. |
| Storage Notes | Store tightly sealed in a cool, dry, well-ventilated place. Protect from moisture, direct sunlight, and elevated temperatures. Long-term storage is recommended at 2–8°C under an inert atmosphere (nitrogen or argon). Avoid repeated exposure to air and humidity. |
| Lead Time | 10 days |
An advanced fused heterocyclic pharmaceutical intermediate used in medicinal chemistry, structure-activity relationship (SAR) studies, and the synthesis of kinase inhibitors, oncology drug candidates, GPCR modulators, and other nitrogen-containing bioactive molecules. Also utilized as a building block for functional organic materials and heteroaromatic compound libraries.